Limbaroc, Teofilo M.
HRN: 08-61-68 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2025
CEFTRIAXONE 1G (VIAL)
11/13/2025
11/19/2025
IV
2g
OD
UTI, Pleural Effusion R
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes